FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to the pharmaceutical industry, in particular to an extract of Pseudolysimachion rotundum var subintegrum for the prevention and treatment of inflammatory disease. Pseudolysimachion rotundum var subintegrum extract for the prevention and treatment of inflammatory diseases, containing 30–60 % (w/w) veprozide, 0.5–10 % (w/w) veratric acid, 2–20 % (w/w) catalposide, 1–10 % (w/w) picroside II, 1–10 % (w/w) isovanyloylcate and 2–20 % (w/w) 6-O-veratroylcatalpol based on the total weight of the extract (100 %) Pseudolysimachion rotundum var subintegrum, where the specified extract obtained by the method, including: adding aqueous ethanol to the dried Pseudolysimachion rotundum var subintegrum at the 1st stage; carrying out the extraction with cold water and then carrying out the extraction under reflux; repeating these steps to obtain the 1st extract in the 2nd stage; suspending said 1st extract in approximately 1–5 times the volume of water to obtain a suspended extract in step 3; adding 1–10 times the volume of butanol, fractionating to obtain an aqueous layer and a butanol layer and collecting the butanol layer to obtain said purified extract, fractionated using butanol (ATS1), at the 3rd stage and purification of the specified purified extract, fractionated using butanol (ATS1), using reverse-phase distribution chromatography using a stationary phase selected from a stationary phase based on silica gel or a stationary phase based on polymer, and a mobile phase selected from the group consisting of water, acetonitrile, methanol, ethanol, butanol, tetrahydrofuran (THF), and mixtures thereof, under certain conditions. Method of obtaining the extract, as well as a pharmaceutical composition.
EFFECT: extract described above has a pronounced anti-inflammatory effect.
3 cl, 15 dwg, 8 ex, 10 tbl
             
         
            
              
                | Title | Year | Author | Number | 
							
              
                | PURIFIED EXTRACT SEPARATED FROM PSEUDOLYSIMACHION ROTUNDUM VAR SUBINTEGRUM WITH HIGH CONTENT OF ACTIVE INGREDIENT, ITS PRODUCTION AND COMPOSITION CONTAINING THE ABOVE EXTRACT AS AN ACTIVE INGREDIENT TO PREVENT OR TREAT INFLAMMATION, ALLERGIES AND ASTHMA | 2013 | 
										Li EnnamYu Chi-SokSin Te-KhiLyu Pen-KhvanO Si-YanAn Ken-SopLi KhenkeKvon Ok-KyunKim Tu-YunKim Chon-KhiSon Khek-Khvan | RU2606768C1 | 
							
              
                | FUNCTIONAL FOOD PRODUCT CONTAINING PURIFIED EXTRACT AFTER SECONDARY FRACTIONATION (ATS2), OBTAINED FROM PSEUDOLYSIMACHION ROTUNDUM VAR SUBINTEGRUM WHITH HIGH CONTENT OF ACTIVE INGREDIENT FOR PREVENTING OR TREATING INFLAMMATION, ALLERGY AND ASTHMA | 2018 | 
										Li EnnamYu Chi-SokSin Te-KhiLyu Pen-KhvanO Si-YanAn Ken-SopLi KhenkeKvon Ok-KyunKim Tu-YunKim Chon-KhiSon Khek-Khvan | RU2682653C1 | 
							
              
                | COMPOSITION CONTAINING PURIFIED EXTRACT, EXTRACTED FROM Pseudolysimachion rotundum var.subintegrum CONTAINING GREAT AMOUNT OF ACTIVE COMPONENT,OR COMPOUNDS, EXTRACTED FROM IT, AS ACTIVE COMPONENT FOR PROPHYLAXIS OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND THEREOF | 2014 | 
										Li EnnamYu Chi-SokSin Te-KhiLyu Pen-KhvanAn Ken SopO Se LyanLi Khen KeSin In SikKim Du EnKvon Ok-KenSon Khek KhvanKim Syn KhenLi Suuj | RU2594061C1 | 
							
              
                | NEW COMPOUND ISOLATED FROM PSEUDOLYSIMACHION ROTUNDUM VAR. SUBINTEGRUM, WITH A HIGH CONTENT OF ACTIVE INGREDIENT, COMPOSITION CONTAINING SAID COMPOUND FOR PREVENTING OR TREATING ALLERGIC DISEASE, INFLAMMATORY DISEASE, ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND USE THEREOF | 2015 | 
										Li EnnamYu Chi-SokSin Te-KhiYu Pen-KhvanO Si-YanAn Ken-SopLi Khen-KeLi Su UjSon Khek-KhvanSin In-SikYu Khen Von | RU2685732C2 | 
							
              
                | NOVEL COMPOUND (KS513) RECOVERED FROM PSEUDOLYSIMACHION ROTUNDUM VAR. SUBINTEGRUM, COMPOSITION CONTAINING SAID COMPOUND AS ACTIVE INGREDIENT, FOR PREVENTING OR TREATING ALLERGIC DISEASE, INFLAMMATORY DISEASE, ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND USE THEREOF | 2016 | 
										Li EnnamYu Chi-SokSin Te-KhiYu Pen-KhvanO Si-YanAn Ken-SopLi Khen-KeLi Su UjSon Khek-KhvanYu Khen Von | RU2713906C2 | 
							
              
                | COMPOSITION CONTAINING EXTRACT OR FRACTION FROM JUSTICIA PLANT | 2015 | 
										Yoon Joo ByoungLee Hyun YongYoum Ji HyunKim Kwang HyunJeon Ji HyunChang Hwan BongHwang Yun HaSeong Seung KyooChoi Dong Rack | RU2671501C1 | 
							
              
                | EXTRACT COPTIDIS RHIZOMA AND ITS USE IN TREATING RESPIRATORY DISEASE | 2009 | 
										Aukh DzhinKim Chang-KhvanKhan Chang-K'JunJeon Sung-KhumShin Jung-DzhunShin Min-KiChang Soo-Im | RU2461388C1 | 
							
              
                | COMPOSITION FOR ASTHMA PREVENTION OR TREATMENT CONTAINING MONOACETHYLDIACYL GLYCERINE COMPOUND AS ACTIVE INGREDIENT | 2014 | 
										O Sej-RyanAn Kyun SopLi Su UiSin In SikSin Na-NeLi Te-SokKan ChonkoChon Yun-SikKhan En-KheSon Ki En | RU2636615C2 | 
							
              
                | COMPOSITION FOR PREVENTION OR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASES CONTAINING MONOACETHYLDIGLYCEROL COMPOUNDS AS ACTIVE INGREDIENT | 2014 | 
										O Sej-RyanAn Kyun SopLi Su UiSin In SikKvon Ok-KyunKim Syn KhyunChun Chan MiLi Te-SokKhan En-KheSon Ki EnKan ChonkoKim Khe Kyun | RU2642631C2 | 
							
              
                | NOVEL APPLICATION OF LIGNAN COMPOUNDS | 2006 | 
										Khvan Dzae-KvanKhan Dzung-SooLim Chol-SeungTszin' DatsinLi Sun-KhiKhan Kiu-Li | RU2354370C1 |